Animal Model of Sclerotic Skin Induced by Bleomycin: A Clue to the Pathogenesis of and Therapy for Scleroderma?
- 31 March 2002
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 102 (3) , 209-216
- https://doi.org/10.1006/clim.2001.5169
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Interferon‐γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor‐β1 in vitroFEBS Letters, 1999
- The tight skin 2 mouseArthritis & Rheumatism, 1995
- New concepts about the mast cellJournal of Allergy and Clinical Immunology, 1994
- Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.Journal of Clinical Investigation, 1993
- Interleukin‐4 stimulates collagen gene expression in human fibroblast monolayer cultures Potential role in fibrosisFEBS Letters, 1992
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?Journal of Investigative Dermatology, 1990
- Systemic scleroderma: Clinical and pathophysiologic aspectsJournal of the American Academy of Dermatology, 1988
- Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injuryBiochemical and Biophysical Research Communications, 1985